Skip to main content
. Author manuscript; available in PMC: 2020 Feb 27.
Published in final edited form as: Acc Chem Res. 2019 May 24;52(6):1687–1696. doi: 10.1021/acs.accounts.9b00137

Figure 1.

Figure 1.

Evolution of translational cardiac regenerative therapies. Chemical engineering strategies were introduced to address the limitations of stem cell therapies for cardiomyocyte regeneration.